Get started
UNITEDHEALTH GROUP INCUNITEDHEALTH GROUP INCUNITEDHEALTH GROUP INC

UNITEDHEALTH GROUP INC

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

UNH trade ideas

UNH: Knife or Generational Opportunity?News today that NYSE:UNH suspended 2025 guidance and CEO stepped down led to a massive route... right down to the 50% Retracement from the 2008 bottom to the former All Time High. This is potentially a big opportunity for a long term position at this level: 322. I would have preferred the level to be matched by a Volume Profile level but the nearest one below is at 244. I can still see a good risk adjusted trade back to the median of the down move initially and onward to a full recovery. I took a moderate position in tax advantaged accounts for the long term hold and will keep an eye on this level for a more tactical setup (a spike or further price action to confirm the hold).
NYSE:UNHLong
by norok
2
Cash printing machine on saleFor all the hatred UNH gets, this company is looking like a buy after this huge sell off. We are approaching the golden ratio around $380. The company generates $100bn in revenue per quarter, hence why it’s a highly regarded cash printing machine. The bearishness may continue as we sit below the 200week MA. I have a worst case scenario of $300 where we have a strong weekly level of support. I think we’ll bottom closer to the mid $300s so I’ll be taking a nibble with a longer term view on this stock. Not financial advice
NYSE:UNHLong
by NoFOMO_
UnitedHealth: Reversal incoming?UnitedHealth: The UNH stock is undergoing a correction phase, with the possibility of further declines into the - support zone. This level is marked as a strong long-term buy opportunity for investors, and price recovery is expected from this zone. Should this correction unfold as anticipated, the stock could rally to and beyond, with potential targets at and in the longer term. Thank you for taking the time to read my analysis. I look forward to reading your thoughts. Best regards, Mattner
NYSE:UNHLong
by MattnerFuture
UnitedHealth Group | UNH | Long at $323.00UnitedHealth Group NYSE:UNH currently has a P/E near 15x, steady rising revenue (2024 = $400+ billion), EPS of 6.24x, dividend of 2.2%, and earnings are forecast to grow by 10.8% per year. The stock, however, has plummeted recently due to negative news, rising healthcare costs, CEO changes, and suspension of 2025 outlook. Every company has bumps, but I view solid companies like NYSE:UNH as pure opportunities for long-term investment - especially with America's aging population. From a technical analysis perspective, the stock price has entered my "crash" simple moving average zone (which currently extends down near $307.00). Personally, this is the zone I am starting a position due to the odds of a future bounce from here. However, I am very aware that there is an open price gap near $265.00 that may get filled this year or early next. I could see a bounce in my crash zone to bring in the bulls and then a drop to that level to heighten the fear. That is another area I plan to grab more shares and build a strong position. But, in case it doesn't extend that low, I have started a position at $223.00, with future investments near $307.00 and below. I doubt this will be a quick turnaround stock - patience is where money is made. Targets (into 2028): $375.00 $475.00 $580.00
NYSE:UNHLong
by WorthlessViews
UNH next strong Support $286As of May 13, 2025, UnitedHealth Group (UNH) stock is experiencing significant volatility due to recent corporate developments: 📉 Current Stock Performance Price: Around $337.02 in premarket trading, down approximately 11% 1. Previous Close: $380.72 2. 📰 Key News CEO Change: Andrew Witty has resigned as CEO for personal reasons. Stephen Hemsley, former CEO (2006–2017), has returned to the role. 2025 Guidance Suspended: UnitedHealth has suspended its 2025 financial outlook due to higher-than-expected Medicare Advantage costs and increased care activity 1. 📊 Analyst Outlook Consensus Rating: Moderate Buy based on 24 analyst ratings. Average Price Target: $596.86, suggesting a potential 56.77% upside from the previous close 2. Price Target Range: $490 to $700. Would you like a chart of UNH’s recent stock performance or a breakdown of analyst ratings over time?
NYSE:UNH
by Hobite
UnitedHealth UNH - Institutional Exit or Long-Term Opportunity?Key Insights UNH has witnessed a historic -24% monthly drop, breaking multiple key long-term supports on extreme volume — often a sign of institutional distribution or capitulation. Bearish Outlook (Primary Bias): Current price is testing the 0.5 Fibonacci retracement ($322 - $287), a critical make-or-break zone. A monthly close below $287 will likely trigger the next leg lower toward $250 and possibly the $200 psychological handle. The bearish momentum remains dominant, confirmed by RSI deep in bear territory and MACD accelerating down. Invalidation Levels (For Shorts): Aggressive short invalidation: Weekly close above $395.33. Full bearish invalidation (shift to bullish bias): Monthly close above $447.21. Bullish Opportunity Zones: Watch for strong bullish reversal at the $287 - $249 support zone, aligning with 0.382 Fib and historical demand. If $200 - $160 is ever reached, it becomes a high-probability accumulation zone for long-term investors. Probability: $395 - $447 Strong Short Bias , Look for retests & rejection $322 - $287 Neutral to Bearish (watch reaction), Currently testing key support $249 - $200 High-Probability Long Setup, Look for confirmation reversal Above $447.21 Bullish Bias Resumes, Invalidate bears, shift to longs Conclusion: UNH is at a critical long-term support crossroad. Patience is key—traders should avoid chasing the lows and wait for higher-probability setups at key levels. Let the chart guide the trade
NYSE:UNH
by truthseeker6
$UNH Rinse & Repeat Round #2- Fundamentally it's undervalued for the quality blue chip company. My detailed analysis is on the older post I made earlier this year. I have attached that as a reference. - In my previous swing, I bought NYSE:UNH on a sell off @ 441 and sold @600 before earning as a de-risking strategy. I'm glad that it did work out. - I'm happy that NYSE:UNH is again trading at a discount and with compressed Earning multiple. This time I am buying it even lower than where I bought last time i.e 441 and I was happy with that price average. - Whereas I do believe that NYSE:UNH EPS is lowered but it is lowered slightly which doesn't warrant a big sell off like this. - I wanted to wait further before entering but I can't stop myself from buying this name NYSE:UNH at a price where I believe it's very undervalued. - Therefore, I have re-entered the NYSE:UNH and added it to my portfolio . I will consider adding further if selling pressure continues because I don't want to time the bottom. - But undecisive market and lumpy market, going with a defensive name like this is a no brainer.
NYSE:UNHLong
by bigbull037
UNH Under Pressure – Below EMA 200 with Heavy Selling VolumeUNH (UnitedHealth) is showing clear bearish signs: Price has dropped below the EMA 200, a key long-term support level Recent sessions show strong selling volume, indicating institutional exit Trend is downward, with no bullish confirmation yet ⚠️ I stay cautious here — waiting for volume shift or price reclaim above EMA before considering a reversal. Until then, the bearish momentum stays active. Not financial advice – just my technical view. #UNH #StockAnalysis #BearishTrend #VolumeAnalysis #EMA200 #TechnicalTrading #HealthcareStocks
NYSE:UNH
by abdeljalillariam
UnitedHealth (UNH) Share Price PlummetsUnitedHealth (UNH) Share Price Plummets UnitedHealth shares crashed by nearly 23% yesterday after the healthcare giant reported weaker-than-expected Q1 2025 results: → Earnings per share: actual = $7.20, expected = $7.29 → Revenue: actual = $109.5bn, expected = $111.5bn Technical Analysis of UNH Share Chart As far back as a year ago, we highlighted key support around the $450 level. Yesterday’s negative news caused this support to once again demonstrate its strength by holding back further decline — but will it hold? Taking the price action marked on the chart as a base, we can establish the structure of a descending channel (shown in red), with the price gapping sharply lower into the bottom half of this channel — and yesterday’s candle high (marked with an arrow) suggests that the median line has turned into resistance. Yesterday’s candle closed near its lows, so it is reasonable to assume that bearish pressure may persist (with the aim of testing the lower boundary) — in which case, the $450 support zone, in place since early 2022, could be at risk. This article represents the opinion of the Companies operating under the FXOpen brand only. It is not to be construed as an offer, solicitation, or recommendation with respect to products and services provided by the Companies operating under the FXOpen brand, nor is it to be considered financial advice.
NYSE:UNH
by FXOpen
1
$UNH buy the fear or sell into narrative?- NYSE:UNH has gotten into trouble with bad headlines after bad headlines. - Recent DOJ probe led to 12% shaving in the stock price. - Could it be a buying opportunity or just a falling knife? - Are you afraid that NYSE:UNH could become NYSE:HUM 2.0? Let's talk about fundamentals! Year | 2024 | 2025 | 2026 | 2027 | 2028 GAAP EPS | 15.76. | 28.22 | 32.11 | 36.80 | 41.11 EPS growth% | -33.47% | 79.08% | 13.77% | 14.61% | 11.71% It appears that 2024/ Early 2025 was the year when EPS growth bottomed and would go from negative to positive back again. EPS growth is healthy double digit in mid teens. A fair forward p/e multiple for mid teen EPS growth should at least be 15 ( conservatively ) Year | 2024 | 2025 | 2026 | 2027 | 2028 Fair Stock Price (w/ forward p/e = 15 ) | $236 | $423 | $481 | $552 | $616 However, NYSE:UNH is a blue chip company and has a moat. Therefore, Investors will be willing to pay forward p/e of 20 once negative news subside. Year | 2024 | 2025 | 2026 | 2027 | 2028 Fair Stock Price (w/ forward p/e = 20 ) | $315 | $564 | $642 | $736 | $822.2 Final Take: I'm a buyer of NYSE:UNH < 450 will add more if it dips below 400 for the long term. Good quality companies don't usually buyers to get their skin into the game. Therefore, it's better to buy the fear than selling into narrative.
NYSE:UNHLong
by bigbull037
5
$UNH: UnitedHealth Group – Healthcare Hero or Reform Risk?(1/9) Good evening, everyone! 🌙 NYSE:UNH : UnitedHealth Group – Healthcare Hero or Reform Risk? With UNH at $505.69, post-7% drop, is this healthcare giant a safe bet or a reform casualty? Let’s diagnose! 🔍 (2/9) – PRICE PERFORMANCE 📊 • Current Price: $ 505.69 as of Mar 18, 2025 💰 • Recent Move: Stable after 7% drop, per user data 📏 • Sector Trend: Healthcare sector mixed with reforms and economic factors 🌟 It’s a steady pulse—let’s see if it’s time to buy or hold! ⚙️ (3/9) – MARKET POSITION 📈 • Market Cap: Approx $465B (920M shares) 🏆 • Operations: Health insurance and services across the U.S. ⏰ • Trend: Leading player with strong fundamentals, per data 🎯 Firm in healthcare, but reforms keep it on its toes! 🏥 (4/9) – KEY DEVELOPMENTS 🔑 • Mixed News: Healthcare reforms debated, earnings reports mixed, per user data 🌍 • Q4 2024 Earnings: Assume beat or miss based on context, per data 📋 • Market Reaction: Stabilized after drop, showing resilience 💡 Navigating through choppy waters! 🛳️ (5/9) – RISKS IN FOCUS ⚡ • Healthcare Reforms: Regulatory changes could impact business 🔍 • Competition: Other insurers and providers in the market 📉 • Economic Slowdown: Reduced consumer spending on healthcare ❄️ It’s a risky prescription—watch the side effects! 🛑 (6/9) – SWOT: STRENGTHS 💪 • Market Leader: Dominant in U.S. healthcare 🥇 • Diversified Portfolio: Insurance and services balance risk 📊 • Financial Strength: Strong earnings and cash flow, per data 🔧 Got the muscle to handle challenges! 🏦 (7/9) – SWOT: WEAKNESSES & OPPORTUNITIES ⚖️ • Weaknesses: Regulatory scrutiny, high debt (if any) 📉 • Opportunities: Aging population, tech advancements in healthcare, per data 📈 Can it capitalize on growth or stumble on weaknesses? 🤔 (8/9) – POLL TIME! 📢 UNH at $505.69—your take? 🗳️ • Bullish: $600+ soon, reforms are manageable 🐂 • Neutral: Steady, risks balance out ⚖️ • Bearish: $450 looms, reforms hit hard 🐻 Chime in below! 👇 (9/9) – FINAL TAKEAWAY 🎯 UNH’s $505.69 price reflects stability after a drop, with mixed news and reforms in play 📈. DCA-on-dips could be a strategy to manage volatility. Gem or bust?
NYSE:UNHLong
by DCAChampion